JYNNEOS

Indicated For

smallpox, mpox

About This Medication

# Bavarian Nordic JYNNEOS Patient Guide: How to Get JYNNEOS at Low or No Cost JYNNEOS (Smallpox and Mpox Vaccine, Live, Non-replicating) is the first FDA-approved vaccine for preventing smallpox and mpox in high-risk adults 18 years and older. While Bavarian Nordic, the manufacturer, does not currently offer a dedicated patient assistance program for free or low-cost JYNNEOS doses, patients may access it through public health programs, healthcare providers, or emerging commercial options as the vaccine transitions from government supply.[5][2][3] ## About JYNNEOS JYNNEOS is a **live, non-replicating vaccine** administered in **two subcutaneous doses, 4 weeks apart**, to help protect against mpox (formerly monkeypox) and smallpox. Real-world data shows **66-89% effectiveness** against mpox with full vaccination.[2] It's indicated for adults at high risk, such as those with mpox exposure, certain occupations (e.g., lab workers handling orthopoxviruses), or during outbreaks.[5] Common side effects include injection site pain, fatigue, and headache; report adverse reactions to Bavarian Nordic at **1-833-365-9596** or VAERS.[1][2] **Important:** JYNNEOS is not a treatment but a preventive vaccine. Consult your healthcare provider to confirm if you're at high risk. Vaccination may not protect everyone.[2] ## Who Qualifies for Assistance? No specific income-based patient assistance program exists from Bavarian Nordic for JYNNEOS as of now. However, access is often **free through public health departments** during outbreaks or for eligible high-risk individuals via government stockpiles.[3][7] Post-commercialization (launched April 2024), private sector purchases apply, but patient assistance programs **may become available**.[7] Check with your state health department or provider for free vaccine access. **Key eligibility factors:** - Age 18+ and high risk for mpox/smallpox.[5] - U.S. resident.[9] (Similar programs for reference) - Potentially uninsured or underinsured, depending on emerging programs. ## Income Eligibility Breakdown Bavarian Nordic has not published income thresholds for JYNNEOS assistance. For context, many pharma patient assistance programs use **400-500% of the Federal Poverty Level (FPL)**. Here's a general table based on 2026 U.S. FPL guidelines (approximate; verify current figures): | Household Size | 400% FPL | 500% FPL | |----------------|----------|----------| | Individual | $60,320 | $75,400 | | Couple | $81,760 | $102,200 | | Family of 3 | $103,200 | $129,000 | | Family of 4 | $124,640 | $155,800 | *Notes:* Without a formal program, income may not apply. Public health access often has no income limits during outbreaks.[3] Contact Bavarian Nordic resources for updates.[1] ## Insurance Requirements Insurance details are unclear without a dedicated program. Vaccines like JYNNEOS may be covered under the **Affordable Care Act** (no cost-sharing for ACIP-recommended vaccines) or Medicare Part D for mpox indications.[2] If commercialized, uninsured patients might qualify for assistance if a program launches.[7] Providers can bill insurance or use government supply. Those with **no third-party vaccine coverage** may have better access to similar programs.[9] ## Step-by-Step Application Process 1. **Consult your doctor:** Discuss risk and get a prescription/recommendation.[2] 2. **Contact local health department:** Many offer JYNNEOS free via public stock, especially for mpox outbreaks.[3] 3. **Call Bavarian Nordic:** Reach **1-833-365-9596** for resources, billing guides, or assistance inquiries.[1] 4. **Check provider portals:** Healthcare providers can order commercial JYNNEOS or access remaining government supply.[3][7] 5. **Monitor for programs:** As commercialization advances, visit jynneos.com/support for updates on patient assistance.[1][8] 6. **Submit via HCP:** If a program emerges, providers typically handle enrollment (e.g., fax or portal).[9] No online patient application is currently available. ## Timeline and Delivery - **Processing:** Public health access can be same-day at clinics; commercial orders may take days to weeks.[3] - **Dosing:** Dose 1, then Dose 2 after 28 days.[2] - **Delivery:** Administered by healthcare providers (subcutaneous injection). No home delivery noted.[1] Expect **up to 1 year eligibility** in similar vaccine programs once enrolled.[9] ## Alternatives if Denied or Ineligible - **Public health clinics:** Free via state programs (e.g., NC Immunization Branch).[3] - **Federally Qualified Health Centers (FQHCs):** Often provide vaccines at low/no cost. - **ACIP recommendations:** No out-of-pocket for most insured.[2] - **Biosimilars:** None available; JYNNEOS is unique.[5] - **Other vaccines:** ACAM2000 (live replicating, for smallpox) in limited cases, but higher risk.[5] - **Global options:** Not applicable for U.S. patients. Contact **1-833-365-9596** for guidance.[1] ## Disclaimer This guide is for informational purposes only and not medical advice. Program details can change; verify with Bavarian Nordic, your provider, or health department. No formal PAP confirmed; access relies on public/commercial channels.[1][7] Vaccination status should be discussed with a healthcare professional. Bavarian Nordic does not guarantee assistance.[8] Word count: 942.

Program information last verified: March 30, 2026